|Last Price$56.84||Day Change (%)-1.10%|
|Open Price$57.60||Day Change ($)-0.63|
|Day Range56.71–57.74||52-Week Range44.66–61.22|
As of Thu 07/24/2014 05:15 PM EST | USD
Research and Markets: New Born Screening Market Report 2014: Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit Analysis
2nd Annual Dave & Dan Classic Raises $408,000 for Credit Unions for Kids Benefiting the Children’s Miracle Network Hospitals
Teradyne Introduces Next Generation UltraFLEX Wireless Test Solution
TowerJazz Announces its 2014 Global Symposium (TGS) Roadmap focused on Expanded Technology Offerings and Increased Manufacturing Capacity
Research and Markets: Global Next-generation Sequencing Market
Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...
You'll be surprised at which funds are poised for a large-growth rebound.
Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...
This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...